Gene Predictis SA, a pioneer in precision medicine field, and Synlab Switzerland SA, a European market leader in medical diagnostics, announce a strategic partnership to jointly commercialize Pill Protect®, an innovative and the best performing genetic test to measure the risk of thrombosis related to use of combined oral contraceptives. The companies will collaborate to promote and provide the test in Switzerland and thus empower the existing women’s health offerings in Switzerland and improve the service to physicians and women.

AGEFI Press release (fr)

Learn more (PDF)